Identification of Hub Genes and Key Pathways in the Emphysema Phenotype of COPD
Overview
Authors
Affiliations
Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition associated with high morbidity and mortality. This study aimed to use weighted gene co-expression network analysis (WGCNA) to explore the molecular pathogenesis of the emphysema phenotype of COPD. After obtaining lung mRNA expression profiles from ten patients with the emphysema phenotype of COPD and eight controls, emphysema-associated gene modules were identified with WGCNA. Among 13 distinct modules, the green-yellow and brown modules showed the strongest correlations with emphysema severity and lung function and were thus selected as hub modules. On gene ontology analysis, these two modules were mainly enriched in immune response, B cell receptor (BCR) signaling pathway, extracellular matrix (ECM) organization, and collagen fibril organization. Pathway analysis primarily showed enrichment in BCR signaling pathways, ECM receptor interaction, and NF-κB and TGF-β signaling pathways for the two hub modules. Several genes, including FCRLA, MS4A1, CD19, FKBP10, C1S and HTRA1, among others, were identified as hub genes. Our results shed light on the potential genetic mechanisms underlying the pathogenesis of the emphysema phenotype of COPD. However, further research will be needed to confirm the involvement of the identified genes and to determine their therapeutic relevance.
Liu Z, Petinrin O, Chen N, Toseef M, Liu F, Zhu Z BMC Infect Dis. 2024; 24(1):1099.
PMID: 39363208 PMC: 11451256. DOI: 10.1186/s12879-024-10000-3.
Lung Transcriptomics Links Emphysema to Barrier Dysfunction and Macrophage Subpopulations.
Lu R, Gregory A, Suryadevara R, Xu Z, Jain D, Morrow J Am J Respir Crit Care Med. 2024; .
PMID: 38935868 PMC: 11755365. DOI: 10.1164/rccm.202305-0793OC.
Serum Metabolomics Reveals Metabolomic Profile and Potential Biomarkers in Asthma.
Zhu T, Ma Y, Wang J, Xiong W, Mao R, Cui B Allergy Asthma Immunol Res. 2024; 16(3):235-252.
PMID: 38910282 PMC: 11199150. DOI: 10.4168/aair.2024.16.3.235.
Liu L, Tang Z, Zeng Q, Qi W, Zhou Z, Chen D J Inflamm Res. 2024; 17:2873-2887.
PMID: 38741612 PMC: 11090121. DOI: 10.2147/JIR.S458580.
Transcriptomic characterization of the human segmental endotoxin challenge model.
Gress C, Litzenburger T, Schmid R, Xiao K, Heissig F, Muller M Sci Rep. 2024; 14(1):1721.
PMID: 38242945 PMC: 10798985. DOI: 10.1038/s41598-024-51547-0.